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This study was designed to identify factors associated with hepatitis A immuni-
zation status and seropositivity in Korean children. In-person interviews,
reviewing their vaccination cards and testing hepatitis A antibody were con-
ducted with 389 children aged 1-3 years and 544 children aged 6-8 years. In all
age groups, earlier birth order was the only significant factor in children
receiving either single or both doses of the vaccination. And completion of the
second dose of vaccination was a prerequisite for increased seropositivity.
Additionally, household income had a positive impact on seropositivity only in
children aged 6-8 years. Our findings suggest that presence of an economic
barrier is the underlying cause of the decreased hepatitis A vaccination services
in Korea. Therefore, hepatitis A vaccine should be included in the essential
National Immunization Program.ted under the terms of the Creative Commons Attribution Non-Commercial License (http://
0) which permits unrestricted non-commercial use, distribution, and reproduction in any
roperly cited.
ase Control and Prevention. Published by Elsevier Korea LLC. All rights reserved.
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Vaccine-preventable diseases are still a public health
burden worldwide [1], and this could be largely attrib-
uted to the prevailing suboptimal vaccination rate [2].
The number of patients infected with the hepatitis A
virus (HAV) has increased dramatically from 1398 in
2001 to 38,811 persons in 2010 [3,4].
Since the hepatitis A vaccine was introduced in
Korea in 1997, the anti-HAV seroprevalence rate in
children under the age of 10 years has increased from
33.4% in 2005 to 69.9% in 2009 [5]. Results of two
studies have confirmed that 50.6% of children have
received the hepatitis A immunization [6], and 42.3%
have received the first dose whereas only 24.7% have
received both doses of the vaccination [7], indicating
that there are significant barriers in accessing immuni-
zation services. Yun et al conducted a study to investi-
gate the seroprevalence and vaccination rates in Korea
[6]. However, the results of the study were inconclu-
sive owing to sampling limitations. In this study,
participants were selected from a hospital (participants
ranged from children under the age of 10 years to
elderly persons older than 80 years of age). Immuniza-
tion status and seropositivity of hepatitis A vaccine and
its related factors among Korean toddlers older than 5
years of age has not yet been studied.
Therefore, we analyzed a population-based sample of
children aged 1e3 years and 6e8 years from a metro-
politan city and a province in Korea to investigate
factors related to the status and seropositivity of hepa-
titis A immunization status.2. Materials and Methods
2.1. Participants
The study population included 392 children aged
1e3 years and 550 children aged 6e8 years living in
a metropolitan city (Daejeon) and three counties
(Nonsan, Geumsan, and Gyeryong) in the Chungnam
Province of Korea. We excluded nine children due to
refusal to collect a blood sample (n Z 3), no vacci-
nation record (n Z 5), or a partially completed inter-
view (n Z 1). A face-to-face interview with 933
caregivers was conducted between July 2010 and
February 2011.
2.2. Questionnaire and outcome measures
We developed a questionnaire that included several
factors such as low family income [8,9], low level of
parental education [8,10], young age of parents [10],
birth order of the child [11,12], and region [6].
We retrospectively assessed the dates of adminis-
tering a first and a second dose of hepatitis A vaccine
by reviewing written records from vaccination cards,
based on the immunization schedule of the KoreanCenters for Disease Control and Prevention [13].
Completed status of immunization was defined as
whether children received both first and second dose of
the vaccine.
The anti-HAV immunoglobulin G test was conducted
by a chemiluminescent microparticle immunoassay
(ARCHITECT; Abbott Laboratories, Abbott Park, IL,
USA). Assay protocols, cutoffs, and interpretations were
carried out according to the manufacturers’ instructions.
Seropositivity was defined as S/CO (relative light units
of sample/relative light units of calibrator) > 1.
2.3. Analysis
Hepatitis A immunization status in the 933 partici-
pants and seropositivity in the 542 immunized partici-
pants were assessed by age group (1e3 years and 6e8
years) using the Chi-square test. Odds ratio (OR) and
95% confidence interval (CI) were calculated by
multiple logistic regression analyses. The models were
constructed to include all independent variables for
which the p value calculated from the Chi-square test
was less than 0.10. All statistical analyses were con-
ducted with SPSS version 20 software (SPSS Inc.,
Chicago, IL, USA).
2.4. Ethical considerations
Informed consents were given for children and their
caregivers who participated voluntarily in this study.
The purpose of the study was explained to them. Names
of the participants were not registered in the question-
naires. An ethical approval was obtained from the
Institutional Review Board at Konyang University,
Korea.3. Results
3.1. Factors affecting hepatitis A immunization
status
Factors playing a significant role in hepatitis A
immunization status are shown in Table 1. Immuniza-
tion status of both first and second doses was signifi-
cantly higher for children aged 1e3 years who had an
earlier birth order (p < 0.001), fewer siblings
(p Z 0.019), and lived in the city (p Z 0.025). Immu-
nization rates of both first and second doses were
significantly higher for children aged 6e8 years who
had an earlier birth order (p < 0.001), fewer siblings
(p Z 0.037), and higher monthly household income
(p Z 0.044).
Multiple logistic regression analysis (Table 2)
revealed that only being first in the birth order was
a contributing factor for higher immunization status
(children aged 1e3 years: OR Z 2.5, 95%
CI Z 1.2e5.0; children aged 6e8 years: OR Z 5.2,
95% CI Z 2.3e11.7).
Table 1. Completed status of hepatitis A immunization by characteristics of children and their caregivers
Predictors
Children aged 1e3 years (389 participants) Children aged 6e8 years (544 participants)
N % p N % p
Child’s factor
Gender
Male 80/200 40.0 0.090 137/271 50.6 0.797
Female 105/189 31.7 135/273 49.5
Birth order
First 85/168 50.6 <0.001 156/240 65.0 <0.001
Second 47/167 28.1 100/246 40.7
Third or more 8/54 14.8 16/58 27.6
Number of siblings
None 44/107 41.1 0.019 38/68 55.9 0.037
One 82/214 38.3 182/347 52.4
Two or more 14/68 20.6 52/129 40.3
Caregiver’s factor
Monthly household income (KRW)
<2,000 36/97 37.1 0.044 36/79 45.6 0.044
2,000e2,999 52/133 39.1 53/121 43.8
3,000e3,999 33/104 31.7 95/187 50.8
4,000 19/55 34.5 88/157 56.1
Age (y)
20e29 31/78 39.7 0.537 7/16 43.8 0.705
30e39 101/289 34.9 212/416 51.0
40 8/22 36.4 53/112 47.3
Region
Rural 41/167 24.6 0.025 118/210 56.2 0.104
Urban 87/222 39.2 161/334 48.2
Educational attainment (y)
12 23/73 31.5 0.084 59/126 46.8 0.291
13 125/316 39.6 217/418 51.9
KRW Z South Korean Won.
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A immunization
Seropositivity in immunized children based on the
predictor variables is shown in Table 3. SeropositivityTable 2. ORs and 95% CIs of receiving both the first dose and
Predictors
Children
1e3 y
Birth order
First 2.5 (1.2
Second 1.1 (0.5
Third or more 1.0
Monthly household income (KRW)
<2,000 d
2,000e2,999 d
3,000e3,999 d
4,000 d
Region
Rural 1.0
Urban 0.9 (0.5
Educational attainment
12 1.0
13 1.2 (0.7
CI Z confidence interval; KRW Z South Korean Won; OR Z odds ratio.was significantly higher for children who had been
administered two doses of the vaccine: 82.4% in chil-
dren aged 1e3 years receiving only first dose and 99.3%
in children receiving both doses (p < 0.001), and 82.2%second dose of hepatitis A immunization
aged
ears
Children aged
6e8 years
e5.0) 5.2 (2.3e11.7)
e2.5) 2.3 (1.0e5.1)
1.0
1.0
1.1 (0.4e2.7)
1.3 (0.6e2.9)
2.2 (0.9e5.6)
1.0
e1.8) 1.5 (0.8e2.7)
d
e2.1) d
Table 3. Seropositivity in children receiving hepatitis A immunization by characteristics of children and caregivers
Predictors
Children aged 1e3 years (225 participants) Children aged 6e8 years (317 participants)
N % p N % p
Child’s factor
Gender
Male 112/120 93.3 0.782 149/158 94.3 0.153
Female 97/105 92.4 155/159 97.5
Birth order
First 110/118 93.2 0.902 168/173 97.1 0.482
Second 80/86 93.0 116/123 94.3
Third or more 19/21 90.5 20/21 95.2
Number of siblings
None 61/69 88.4 0.199 41/44 93.2 0.914
One 121/127 95.3 204/210 97.1
Two or more 27/29 93.1 59/63 93.7
Immunization doses
One 70/85 82.4 <0.001 37/45 82.2 <0.001
Two 139/140 99.3 267/272 98.2
Caregiver’s factor
Monthly household income (KRW)
<2,000 52/56 92.9 0.966 38/41 92.7 0.047
2,000e2,999 70/75 93.3 60/64 93.8
3,000e3,999 59/64 92.2 109/114 95.6
4000 28/30 93.3 97/98 99.0
Age (y)
20e29 43/45 95.6 0.207 10/11 90.9 0.271
30e39 156/168 92.9 234/241 97.1
40 10/12 83.3 60/65 92.3
Region
Rural 28/31 90.3 0.549 81/84 96.4 0.775
Urban 181/194 93.3 223/233 95.7
Educational attainment (y)
12 84/88 95.5 0.230 106/113 93.8 0.162
13 125/137 91.2 198/204 97.1
KRW Z South Korean Won.
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98.2% in children receiving both doses (p < 0.001). We
observed a significant positive relationship between
monthly household income and seropositivity in chil-
dren aged 6e8 years (p Z 0.047).
The multiple logistic regression analysis (Table 4)
revealed that administration of two doses of the hepatitisTable 4. ORs and 95% CIs of seropositivity in children receiv
Predictors Children aged 1e3
Immunization doses
One 1.0
Two 139.0 (19.4e993
Monthly household income (KRW)
<2,000 d
2,000e2,999 d
3,000e3,999 d
4,000 d
CI Z confidence interval; KRW Z South Korean Won; OR Z odds ratio.A vaccine was a contributing factor for seropositivity
(children aged 1e3 years: OR Z 139.0, 95%
CI Z 19.4e993.7; children aged 6e8 years:
OR Z 59.2, 95% CI Z 8.1e432.7). A positive rela-
tionship was observed between monthly household
income and seropositivity in children aged 6e8 years
[2000e<3000 South Korean Won (KRW) group:ing hepatitis A immunization
years Children aged 6e8 years
1.0
.7) 59.2 (8.1e432.7)
1.0
3.8 (1.4e10.2)
5.3 (2.1e13.9)
4.7 (1.0e21.5)
Hepatitis A immunization among Korean children 97OR Z 3.8, 95% CI Z 1.4e10.2; 3000e<4000 KRW
group: OR Z 5.3, 95% CI Z 2.1e13.9; 4000 KRW
group: OR Z 4.7, 95% CI Z 1.0e21.5].4. Discussion
Because of growing concerns about hepatitis A in
Korea, the Korean Ministry of Health and Welfare
changed the classification of hepatitis A in 2011 into
a first-class communicable disease, a category that
includes foodborne diseases or waterborne diseases with
the possibility of rapid transmission and the need for
urgent countermeasures [14]. Hepatitis A immunization
is the most effective measure to curtail this disease and
was introduced in 1997. However, hepatitis A vaccina-
tion is not part of the National Immunization Program
(NIP) in South Korea; thus, patients must pay to receive
the vaccination, which probably serves as a barrier to
access the service [15].
This study has for the first time provided results of
hepatitis A immunization status and seropositivity in
children in Korea. Our findings illustrate that earlier
birth order was a contributing factor for hepatitis A
immunization rates. This result was consistent with
other studies that late birth order in the family has
a negative effect on complete vaccination status
[12,16]. However, this result was inconsistent with that
of another study [17] in which low hepatitis A vacci-
nation coverage in Korea was significantly related to
economic status, rural area, and a mother’s employ-
ment status.
Because the hepatitis A vaccine was not included in
the essential NIP in Korea, caregivers whose children
wish to receive the vaccination must pay for the service
[18], and this seems to decrease the number of patients
who avail this service. Therefore, there have been
several arguments that HAV vaccination must be
included in the NIP [19]. The number of people
receiving two doses of the hepatitis A vaccine in Korea
has been estimated at 41.6% based on the number of
hepatitis A vaccines sold between 1998 and 2006 [20]
and 24.7% based on a 2005 population-based survey
[7]. Unfortunately, our study was not designed to
provide hepatitis vaccination rates. Nevertheless, we
hypothesize that a larger number of children implies
higher vaccination costs for caregivers and these costs
are likely to be a powerful contributing factor to the
significant decrease in patients accessing hepatitis A
vaccination services in these larger families in Korea. In
addition, because in Korea it is not mandatory to
maintain hepatitis A vaccination records by either the
caregivers or health-care providers, it is impractical to
get the complete vaccination status of the population.
The latter problem is compounded by the fact that the
vaccinations are administered in a private clinic whose
records are not easily accessible.Our findings illustrate that the number of immuni-
zation doses and household income are predictors of
hepatitis A seropositivity. Our findings demonstrated
that the location of residence (rural/urban) has no impact
on seropositivity, which is inconsistent with the results
of a previous study [6] that showed that children living
in rural areas have higher seropositive rates compared
with those living in the city.
In this study, seropositivity was considered to be an
indicator of the effects of hepatitis A vaccination. In
2006, HAV seroprevalence was reported to be 55.6% in
children aged 1e4 years and 47.2% in those aged 5e9
years [21]. More than 90% of children aged 1 year or
more and adults had protective titers of the antibody 4
weeks after administering one dose of the vaccination
[22] and anti-HAV persists for at least 10e12 years after
vaccination in 5e6-year-old children [23]. Thus,
a second dose of the vaccination 2e8 years after the
single primary dose shows an excellent booster response
[24e26].
Our findings are based only on analysis of data
derived from children living in restricted areas in Korea
and are not representative of the national estimate of
hepatitis A vaccination coverage. Previous studies have
demonstrated that the vaccination records can be
incomplete [27], and because written records of vacci-
nation for our analysis are not available, the accuracy of
the assessment of the immunization’s completeness is
decreased. Because of excluding children without the
written vaccination records, children with disadvantaged
caregivers were possibly excluded. This bias is likely to
result in an underestimation of the impact of the
observed predictor variables on hepatitis A immuniza-
tion rates and seropositivity.Acknowledgments
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